Company: PTPI
Filing Date: 2025-02-14
Form Type: S-1MEF
Source: 0001104659-25-014398
Chunk: 0

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-1MEF
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on February 14, 2025.</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

Petros Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)</div>

| Delaware                        |                                        2834 | 85-1410058            |
| (State or other jurisdiction of 
 incorporation or organization)  | -primary standard industrial classification 
                                 code number | -I.R.S. Employer      
 Identification Number |

<div align='center'>1185 Avenue of the Americas, 3 rdFloor

New York, New York 10036

(973) 242-0005

(Address, including zip code, and telephone number, including

area code, of registrant’s principal executive offices)

Fady Boctor

President and Chief Commercial Officer

Petros Pharmaceuticals, Inc.

1185 Avenue of the Americas, 3 rdFloor

New York, New York 10036

(973) 242-0005

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:</div>

| Rick A. Werner, Esq.             
 Alla Digilova, Esq.              
 Haynes and Boone, LLP            
 30 Rockefeller Plaza, 26th Floor 
 New York, NY 10112               
 212-659-7300                     | M. Ali Panjwani, Esq.    
 David E. Fisher, Esq.    
 Pryor Cashman LLP        
 7 Times Square           
 New York, New York 10036 
 (212) 421-4100           |

Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this Registration Statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box.☐

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.☒ 333-284495

If this Form is a post-effective